Page last updated: 2024-08-21

diphenylamine and Myeloproliferative Disorders

diphenylamine has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akutagawa, JK; Braun, BS; Gorman, MF; Hong, WX; Lauchle, JO; Lyubynska, N; Shannon, K	1

Other Studies

1 other study(ies) available for diphenylamine and Myeloproliferative Disorders

Article	Year
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Science translational medicine, 2011, Mar-30, Volume: 3, Issue:76 Topics: Animals; Benzamides; Cell Differentiation; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Mutation; Myeloproliferative Disorders; Myxovirus Resistance Proteins; Neoplasms; Proto-Oncogene Proteins p21(ras); raf Kinases; Random Allocation; Recombinant Fusion Proteins	2011

Article

Year

A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.

Science translational medicine, 2011, Mar-30, Volume: 3, Issue:76

Topics: Animals; Benzamides; Cell Differentiation; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Mutation; Myeloproliferative Disorders; Myxovirus Resistance Proteins; Neoplasms; Proto-Oncogene Proteins p21(ras); raf Kinases; Random Allocation; Recombinant Fusion Proteins

2011